2017
DOI: 10.1016/j.clim.2017.01.013
|View full text |Cite
|
Sign up to set email alerts
|

Non-receptor type, proline-rich protein tyrosine kinase 2 (Pyk2) is a possible therapeutic target for Kawasaki disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0

Year Published

2019
2019
2021
2021

Publication Types

Select...
6
1

Relationship

2
5

Authors

Journals

citations
Cited by 8 publications
(6 citation statements)
references
References 43 publications
0
6
0
Order By: Relevance
“…C57Bl/6 and BALB/c mice are the most frequently used inbred strains for immunological research and the establishment of gene knockout mice. [12][13][14][15] the presence of α-1,2-, α-1,3-, and α-1,6mannose links. [66][67][68] The spectral patterns shown in Figure 5 were similar to those in their studies and consistent with these findings.…”
Section: Biological and Pharmaceutical Bulletin Advance Publicationmentioning
confidence: 98%
“…C57Bl/6 and BALB/c mice are the most frequently used inbred strains for immunological research and the establishment of gene knockout mice. [12][13][14][15] the presence of α-1,2-, α-1,3-, and α-1,6mannose links. [66][67][68] The spectral patterns shown in Figure 5 were similar to those in their studies and consistent with these findings.…”
Section: Biological and Pharmaceutical Bulletin Advance Publicationmentioning
confidence: 98%
“…KD-like vasculitis can be induced in rabbit, swine, and mouse models by various methods (80)(81)(82)(83). The known genetic background and ease of genetic manipulation have made mouse models the preferred model to investigate molecular pathogenesis of KD and to discover its therapeutic targets (84)(85)(86)(87)(88).…”
Section: Insight From Experimental Studies With Animal Model For Kdmentioning
confidence: 99%
“…Ptk2b has been found acting as a negative regulator in many biological functions and consequently suggests as a potential target for some diseases through its inhibition (Lipinski & Loftus, 2010; Suzuki et al, 2017). For example, Ptk2b has been found as a new susceptibility locus of late‐onset Alzheimer's disease (AD; Chan et al, 2015; Kamboh et al, 2012; Lambert et al, 2013; Y. Q. Li et al, 2016; Lin et al, 2017), and the expression of Ptk2b increased in the brains of patients with AD (Padhy, Hayat, Nanda, Mohanty, & Alone, 2017).…”
Section: Discussionmentioning
confidence: 99%